Copyright
©The Author(s) 2016.
World J Methodol. Mar 26, 2016; 6(1): 93-100
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.93
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.93
Age (gender) group | Percentile value,μmol/L | |
2.5th | 97.5th | |
Common reference intervals for global application | ||
Cord sera | 46 | 86 |
Term neonates 0-14 d | 27 | 81 |
2 mo - < 1 yr | 14 | 34 |
1 yr - < 3 yr | 15 | 31 |
3 yr - < 5 yr | 23 | 37 |
5 yr - < 7 yr | 25 | 42 |
7 yr - < 9 yr | 30 | 48 |
9 yr - < 11 yr | 28 | 57 |
11 yr - < 13 yr | 37 | 63 |
13 yr - < 15 yr | 40 | 72 |
Adult (males) | 64 | 104 |
Adult (females) | 49 | 90 |
Reference intervals in the reference sample group of Croatian population (n = 240) | ||
Adult (males) | 54 | 107 |
Adult (females) | 50 | 93 |
Analyte | Method | Unit | Reference interval | Ref. | Verification (%) | ||
Sex | Age (yr) | Interval | |||||
ALT | Photometry UV, IFCC method, 37 °C, TRIS buffer, L-alanine, α-ketoglutarate, pyridoxal phosphate, NADH, lactate dehydrogenase, pH 7.15: CCMB recommendation for the Croatian population | U/L | Male, female | 0-2 | 11-46 | [40] | |
Male, female | 3-7 | 9-20 | [40] | ||||
Male, female | 8-12 | 11-37 | [10,15] | ||||
Male | 13-19 | 10-33 | [10,15] | ||||
Female | 13-19 | 10-29 | [10,15] | ||||
Male | ≥ 20 | 12-48 | [14] | ||||
Female | ≥ 20 | 10-36 | [14] | ||||
IFCC reference measurement procedure (IFCC RMS), IFCC IRMM reference material ERM-AD454 (2002): Common multicentric reference intervals for the adult population, 2010 | U/L | Male | 18-85 | 9-59 | [41] | 96 | |
Female | 18-85 | 8-41 | 96 | ||||
Pediatric reference intervals | |||||||
CALIPER, Canada, 2012; IFCC reference measurement procedure, Abbott Architect | Male, female | 0 < 1 | 5-51 | [42] | |||
Male, female | 1 < 13 | 11-30 | 90 | ||||
Male | 13 < 19 | 10-33 | 55 | ||||
Female | 13 < 19 | 8-24 | 65 | ||||
Denmark (NORIP), 2012; IFCC reference measurement procedure, Roche Modular | Male | 5-8 | 8-27 | [43] | |||
Male | 9-13 | 8-37 | |||||
Male | 14-18 | 8-47 | |||||
Female | 5-18 | 8-32 | |||||
Germany (a posteriori, ambulance and hospital populations) 2009; IFCC reference measurement procedure, Roche Modular | Male, female | 0-1 | < 49 | [44] | |||
Male, female | 1-3 | < 29 | |||||
Male, female | 4-6 | < 39 | |||||
Male, female | 7-12 | < 44 | |||||
Male | 13-17 | < 51 | |||||
Female | 13-17 | < 45 |
Analyte | Method | Unit | Reference interval | Ref. | Verification (%) | ||
Sex | Age (yr) | Interval | |||||
AST | Photometry UV, IFCC method, 37 °C, TRIS buffer, L-aspartate, α-ketoglutarate, pyridoxal phosphate, NADH, malate dehydrogenase, lactate dehydrogenase, pH 7.65: CCMB recommendation for the Croatian population | U/L | Male, female | 0-2 | 26-75 | [40] | |
Male, female | 3-7 | 24-49 | [40] | ||||
Male, female | 8-12 | 14-39 | [10,15] | ||||
Male | 13-19 | 11-38 | [10,15] | ||||
Female | 13-19 | 14-32 | [10,15] | ||||
Male | ≥ 20 | 11-38 | [14] | ||||
Female | ≥ 20 | 8-30 | [14] | ||||
IFCC reference measurement procedure (IFCC RMS), IFCC IRMM reference material ERM-AD457 (2002): Common multicentric reference intervals for the adult population, 2010 | U/L | Male, female | 18-85 | 11-34 | [41] | 94 | |
Pediatric reference intervals | |||||||
CALIPER, Canada, 2012; IFCC reference measurement procedure, Abbott Architect | Male, female | 1 < 7 | 26-55 | [42] | 100 | ||
Male, female | 7 < 12 | 22-41 | 96 | ||||
Male | 12 < 19 | 18-40 | 96 | ||||
Female | 12 < 19 | 17-33 | 96 | ||||
Denmark (NORIP), 2012; IFCC reference measurement procedure, Roche Modular | Male, female | 5-18 | 17-46 | [43] | |||
Germany (a posteriori, ambulance and hospital populations) 2009; IFCC reference measurement procedure, Roche Modular | Male, female | 0-1 | < 77 | [44] | |||
Male, female | 1-3 | < 71 | |||||
Male, female | 4-6 | < 53 | |||||
Male, female | 7-12 | < 48 | |||||
Male | 13-17 | < 42 | |||||
Female | 13-17 | < 44 |
- Citation: Flegar-Meštrić Z, Perkov S, Radeljak A. Standardization in laboratory medicine: Adoption of common reference intervals to the Croatian population. World J Methodol 2016; 6(1): 93-100
- URL: https://www.wjgnet.com/2222-0682/full/v6/i1/93.htm
- DOI: https://dx.doi.org/10.5662/wjm.v6.i1.93